FDA Appoints Dr. Michelle Tarver as Director

Dr. Michelle Tarver has been appointed as the permanent director of the FDA's Center for Devices and Radiological Health (CDRH) after serving as acting director since July. With over 15 years at the FDA, she brings expertise as an ophthalmologist and epidemiologist, focusing on patient engagement and safety in medical device regulation. FDA Commissioner Robert Califf highlighted her commitment to data-driven decision-making and collaboration within the agency. Tarver aims to prioritize health equity and patient preferences, emphasizing a compassionate approach to healthcare. She faces significant challenges, including restoring trust in the division and addressing concerns over safety standards amidst rapid technological advancements. The medtech community has expressed optimism about her leadership and vision for the agency's future.